In its most recent classification paper, the International League Against Epilepsy (ILAE) introduced the new etiological category of “immune epilepsy.” The ILAE herewith referred to the emerging group of autoimmune encephalitides and explicitly mentioned antibodies against the N-methyl-d-aspartate receptor (NMDAR) and leucine-rich glioma inactivated protein 1 (LGI1) [40]. Here, LGI1 is linked to epilepsy.